The Integrated Impact of Metabolic, Dietary, Environmental, and Psychological Factors on Psoriasis – An Interdisciplinary Perspective on an Inflammatory Skin Disease
DOI:
https://doi.org/10.12775/QS.2025.43.62416Keywords
Psoriasis, Inflammation, Diet, Obesity, Omega-3, PolyphenolsAbstract
Introduction, purpose: Psoriasis is a chronic, non-infectious skin disease. It is estimated that approximately 2–3% of the global population is affected by this condition. Its prevalence varies geographically — higher rates are observed in Europe and North America, while lower rates are noted in Asia and Africa. The development of psoriasis is influenced by genetic predisposition, immune system dysfunction, as well as environmental factors. Psoriasis is not only a dermatological issue characterized by excessive keratinocyte proliferation, but also a systemic inflammatory disease that impacts the patient’s psycho-emotional well-being and carries an increased risk of numerous complications.
Materials and methods: A literature review was conducted using the PubMed database to analyze the impact of patients' lifestyle on the course of psoriasis and the development of complications associated with this condition.
Basic results: A holistic approach to patient care, which takes into account the various factors influencing the course of the disease and identifies areas of life that can be modified to enhance the overall health of the patient, is of significant importance in the pathogenesis of psoriasis.
Conclusions: Although topical and systemic medications remain the cornerstone of psoriasis treatment, lifestyle modifications and health-promoting behaviors can contribute to a milder disease course, reduce the frequency of relapses, and lower the risk of comorbidities.
References
1. Elsadek HM, Ali MS, Elaidy AM. Impact of Genital and Non-Genital Psoriasis on Genital Self-Image, Quality of Life, and Sexual Dysfunction in Female Patients. Dermatol Pract Concept. 2024 Jul 1;14(3):e2024159. doi: 10.5826/dpc.1403a159. PMID: 39122501; PMCID: PMC11313826.
2. Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discov Today. 2020 Dec;25(12):2212-2226. doi: 10.1016/j.drudis.2020.09.023. Epub 2020 Oct 2. PMID: 33011340.
3. Cai Z, Wang W, Zhang Y, Zeng Y. Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice. Immun Inflamm Dis. 2023 Aug;11(8):e967. doi: 10.1002/iid3.967. PMID: 37647442; PMCID: PMC10411394
4. Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008 May;128(5):1207-11. doi: 10.1038/sj.jid.5701213. Epub 2008 Jan 17. PMID: 18200064.
5. Bień B, Krajewski PK, Szepietowski JC. Life-Changing Decisions in Patients Suffering from Psoriasis: A Cross-Sectional Study. Dermatol Ther (Heidelb). 2025 Mar 6. doi: 10.1007/s13555-025-01370-w. Epub ahead of print. PMID: 40050518.
6. Foks-Ciekalska A, Jarząb J, Bożek A, Hadas E, Ziółkowska-Banasik D, Gumieniak K, Ciekalski W. The vicious circle effect: stress as effect and cause in patients with psoriasis. Postepy Dermatol Alergol. 2023 Jun;40(3):362-367. doi: 10.5114/ada.2022.120452. Epub 2022 Oct 22. PMID: 37545823; PMCID: PMC10399666.
7. Zhou H, Wu R, Kong Y, Zhao M, Su Y. Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis. J Int Med Res. 2020 Oct;48(10):300060520964024. doi: 10.1177/0300060520964024. PMID: 33121308; PMCID: PMC7780610.
8. Shen F, Ding Y, Wang R. Impact of tobacco smoking and alcohol consumption on the treatment efficacy among psoriasis patients: A study protocol. Tob Induc Dis. 2024 Nov 20;22. doi: 10.18332/tid/195380. PMID: 39569104; PMCID: PMC11577767.
9. Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. Managing the Patient with Psoriasis and Metabolic Comorbidities. Am J Clin Dermatol. 2024 Jul;25(4):527-540. doi: 10.1007/s40257-024-00857-0. Epub 2024 May 15. PMID: 38748391; PMCID: PMC11193697.
10. Pinter A, Schwarz P, Gerdes S, Simon JC, Saalbach A, Rush J, Melzer N, Kramps T, Häberle B, Reinhardt M. Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients. 2021 Aug 29;13(9):3015. doi: 10.3390/nu13093015. PMID: 34578893; PMCID: PMC8471656.
11. Puig L. Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1007-11. doi: 10.1111/j.1468-3083.2011.04065.x. Epub 2011 Apr 15. PMID: 21492252.
12. Yeroushalmi S, Hakimi M, Chung M, Bartholomew E, Bhutani T, Liao W. Psoriasis and Exercise: A Review. Psoriasis (Auckl). 2022 Jul 2;12:189-197. doi: 10.2147/PTT.S349791. PMID: 35813078; PMCID: PMC9258800.
13. Ismail AMA, Hamed DE. Erectile dysfunction and metabolic syndrome components in obese men with psoriasis: response to a 12-week randomized controlled lifestyle modification program (exercise with diet restriction). Ir J Med Sci. 2024 Feb;193(1):523-529. doi: 10.1007/s11845-023-03412-8. Epub 2023 May 31. PMID: 37258850; PMCID: PMC10808673.
14. Yongpisarn T, Thadanipon K, Suchonwanit P, Rattanakaemakorn P. Hyperglycemia Is a Potential Prognostic Factor for Exacerbation in Severe Psoriasis with Diabetes or Prediabetes. Clin Cosmet Investig Dermatol. 2025 Feb 6;18:345-353. doi: 10.2147/CCID.S502333. PMID: 39931717; PMCID: PMC11809405
15. Wang R, Yu C, Tang Z, Sun J, Wang Y, Zhao Z, Lin B, Li C. Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: implications for metabolic syndrome-induced resistance of psoriatic therapy. J Dermatolog Treat. 2024 Dec;35(1):2309305. doi: 10.1080/09546634.2024.2309305. Epub 2024 Jan 31. PMID: 38297481.
16. Guerrero Aznar MD, Villanueva Guerrero MD, Beltrán García M, Hernández Cruz B. Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood-Could the Comparison Between Diets Be Improved? Nutrients. 2025 Jan 29;17(3):493. doi: 10.3390/nu17030493. PMID: 39940351; PMCID: PMC11819864.
17. De Simoni E, Rizzetto G, Molinelli E, Capodaglio I, Offidani A, Simonetti O. The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues. Nutrients. 2023 Mar 31;15(7):1705. doi: 10.3390/nu15071705. PMID: 37049545; PMCID: PMC10097110.
18. Katsimbri P, Korakas E, Kountouri A, Ikonomidis I, Tsougos E, Vlachos D, Papadavid E, Raptis A, Lambadiari V. The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool? Antioxidants (Basel). 2021 Jan 22;10(2):157. doi: 10.3390/antiox10020157. PMID: 33499118; PMCID: PMC7912156.
19. Wang Q, Wang J, Sun X, Liu L, Zhang M, Yu Y, Gao P, Hong S, Li X. Evidence-based dietary recommendations for patients with psoriasis: A systematic review. Clin Nutr. 2025 Apr;47:68-82. doi: 10.1016/j.clnu.2025.02.005. Epub 2025 Feb 15. PMID: 39987781.
20. Annunziata G, Verde L, Zink A, Muscogiuri G, Albanesi C, Paganelli A, Barrea L, Scala E. Plant-Based Foods for Chronic Skin Diseases: A Focus on the Mediterranean Diet. Curr Nutr Rep. 2025 Mar 6;14(1):42. doi: 10.1007/s13668-025-00632-5. PMID: 40048018; PMCID: PMC11885338.
21. Krajina I, Štefanić M, Drenjančević I, Milić J, Kolobarić N, Plužarić V, Tokić S, Matijević T, Tolušić Levak M, Kožul M, Šola M, Stupin A, Mihalj M. Two-Week Low-Salt Diet Improves Acetylcholine-Induced Microvascular Dilation in Biologically Naïve Psoriasis Patients. Nutrients. 2025 Feb 14;17(4):693. doi: 10.3390/nu17040693. PMID: 40005022; PMCID: PMC11858809.
22. Radu A, Tit DM, Endres LM, Radu AF, Vesa CM, Bungau SG. Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions. Inflammopharmacology. 2025 Feb;33(2):527-549. doi: 10.1007/s10787-024-01602-z. Epub 2024 Nov 22. PMID: 39576422; PMCID: PMC11842495.
23. Clark CCT, Taghizadeh M, Nahavandi M, Jafarnejad S. Efficacy of ω-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2019 Apr;38(4):977-988. doi: 10.1007/s10067-019-04456-x. Epub 2019 Feb 18. PMID: 30778861.
24. Chen X, Hong S, Sun X, Xu W, Li H, Ma T, Zheng Q, Zhao H, Zhou Y, Qiang Y, Li B, Li X. Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials. Nutr Rev. 2020 Oct 1;78(10):827-840. doi: 10.1093/nutrit/nuz098. PMID: 31995220.
25. Di Salvo E, Gangemi S, Genovese C, Cicero N, Casciaro M. Polyphenols from Mediterranean Plants: Biological Activities for Skin Photoprotection in Atopic Dermatitis, Psoriasis, and Chronic Urticaria. Plants (Basel). 2023 Oct 15;12(20):3579. doi: 10.3390/plants12203579. PMID: 37896042; PMCID: PMC10609915.
26. Zhang J, Ma Y, Li W. Curcumin reduces inflammation in mice with the psoriasis model by inhibiting NLRP3 inflammatory bodies. Cell Mol Biol (Noisy-le-grand). 2022 Feb 27;67(6):48-54. doi: 10.14715/cmb/2021.67.6.7. PMID: 35818215.
27. Tsiogkas SG, Apostolopoulou K, Mavropoulos A, Grammatikopoulou MG, Dardiotis E, Zafiriou E, Bogdanos DP. Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis. Immunol Res. 2023 Jun;71(3):475-487. doi: 10.1007/s12026-023-09361-9. Epub 2023 Feb 9. PMID: 36754913; PMCID: PMC10185625.
28. Oliveira ALB, Monteiro VVS, Navegantes-Lima KC, Reis JF, Gomes RS, Rodrigues DVS, Gaspar SLF, Monteiro MC. Resveratrol Role in Autoimmune Disease-A Mini-Review. Nutrients. 2017 Dec 1;9(12):1306. doi: 10.3390/nu9121306. PMID: 29194364; PMCID: PMC5748756.
29. Zhang L, Huang Z, Xuan J, Yang L, Zhao T, Peng W. Anti-Psoriatic Activity of Black, Green and White Tea Extracts from Southeastern China. Molecules. 2024 Mar 13;29(6):1279. doi: 10.3390/molecules29061279. PMID: 38542915; PMCID: PMC10976064.
30. Ruan P, Yang M, Lv X, Shen K, Chen Y, Li H, Zhao D, Huang J, Xiao Y, Peng W, Wu H, Lu Q. Metabolic shifts during coffee consumption refresh the immune response: insight from comprehensive multiomics analysis. MedComm (2020). 2024 Jun 17;5(7):e617. doi: 10.1002/mco2.617. PMID: 38887468; PMCID: PMC11181901.
31. Barrea L, Muscogiuri G, Di Somma C, Annunziata G, Megna M, Falco A, Balato A, Colao A, Savastano S. Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff? Arch Toxicol. 2018 May;92(5):1831-1845. doi: 10.1007/s00204-018-2193-0. Epub 2018 Mar 28. PMID: 29594327.
32. Jordan A, Näslund-Koch C, Vedel-Krogh S, Egil Bojesen S, Skov L. Alcohol consumption and risk of psoriasis: Results from observational and genetic analyses in more than 100,000 individuals from the Danish general population. JAAD Int. 2024 Mar 20;15:197-205. doi: 10.1016/j.jdin.2024.03.003. PMID: 38707928; PMCID: PMC11066682.
33. Xue M, Deng Q, Deng L, Xun T, Huang T, Zhao J, Wei S, Zhao C, Chen X, Zhou Y, Liang Y, Yang X. Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review. Eur J Pharmacol. 2025 Mar 17;998:177521. doi: 10.1016/j.ejphar.2025.177521. Epub ahead of print. PMID: 40107339.
34. López-Sánchez C, Puig L. Guselkumab in the treatment of moderate-to-severe plaque psoriasis. Immunotherapy. 2020 Apr;12(6):355-371. doi: 10.2217/imt-2020-0040. Epub 2020 Apr 21. Erratum in: Immunotherapy. 2020 Jul;12(10):757. doi: 10.2217/imt-2020-0040c1. PMID: 32314622.
35. Memariani M, Memariani H. New horizons in the treatment of psoriasis: Modulation of gut microbiome. Heliyon. 2025 Jan 3;11(1):e41672. doi: 10.1016/j.heliyon.2025.e41672. PMID: 39866422; PMCID: PMC11760288.
36. Yin G, Li JF, Sun YF, Ding X, Zeng JQ, Zhang T, Peng LH, Yang YS, Zhao H. [Fecal microbiota transplantation as a novel therapy for severe psoriasis]. Zhonghua Nei Ke Za Zhi. 2019 Oct 1;58(10):782-785. Chinese. doi: 10.3760/cma.j.issn.0578-1426.2019.10.011. PMID: 31594178.
37. Nordgren M, Duvetorp A. Psychosocial impact of climatotherapy in young patients with psoriasis: a 3-month cohort study. Front Med (Lausanne). 2024 Oct 29;11:1458394. doi: 10.3389/fmed.2024.1458394. PMID: 39534221; PMCID: PMC11554493.
38. Zhang M, Wang Y, Hu S, Wu Y. Causal relationships between air pollution and common autoimmune diseases: a two-sample Mendelian randomization study. Sci Rep. 2025 Jan 2;15(1):135. doi: 10.1038/s41598-024-83880-9. PMID: 39747919; PMCID: PMC11697238.
39. Xiong Y, Xia Y, Zhang X, Jiang B, Zhang Z, Xie C, Miao X, Lan J, Tao J. Joint exposure to multiple air pollutants, genetic risk and incident psoriasis: a large-scale prospective cohort study. Br J Dermatol. 2025 Feb 18;192(3):420-429. doi: 10.1093/bjd/ljae391. PMID: 39395185.
40. Mao R, Zhang T, Zhong Y, Meng X, Yi C, Wang F, Li J. Associations between domestic hard water exposure and incident psoriasis in adults: Insights from the UK Biobank cohort study. J Autoimmun. 2025 Feb;151:103373. doi: 10.1016/j.jaut.2025.103373. Epub 2025 Jan 24. PMID: 39862482.
41. Hołdrowicz A, Żebrowska A. Molecular Link Between Psoriasis and Depression-Update on Pathophysiology. Int J Mol Sci. 2025 Mar 10;26(6):2467. doi: 10.3390/ijms26062467. PMID: 40141110; PMCID: PMC11942400.
42. Siteneski A, Montes-Escobar K, de la Hoz-M J, Lapo-Talledo GJ, Gutiérrez Moreno G, Carlin Chavez E, Caicedo Quiroz R, Borja-Cabrera GP. Depression and Anxiety in Patients with Psoriasis: A Comprehensive Analysis Combining Bibliometrics, Latent Dirichlet Allocation, and HJ-Biplot. Healthcare (Basel). 2025 Feb 20;13(5):441. doi: 10.3390/healthcare13050441. PMID: 40077004; PMCID: PMC11899133.
43. Jalenques I, Bourlot F, Martinez E, Pereira B, D'Incan M, Lauron S, Rondepierre F. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis. Acta Derm Venereol. 2022 Aug 26;102:adv00769. doi: 10.2340/actadv.v102.1386. PMID: 35604236; PMCID: PMC9558761.
44. Kuryłło M, Mojs E, Woźniak N, Wiśniewska-Szeplewicz D. Do Psoriasis and Atopic Dermatitis Affect Memory, Attention, Stress and Emotions? Brain Sci. 2024 Jul 25;14(8):747. doi: 10.3390/brainsci14080747. PMID: 39199442; PMCID: PMC11352270.
45. Mann C, Wollenberg A, Ständer S, Staubach P, Thaçi D, Zirpel H. Risk of developing sleep disorders and psychologic comorbidity in children with inflammatory skin diseases-A population-based study. J Am Acad Dermatol. 2025 Feb 6:S0190-9622(25)00191-4. doi: 10.1016/j.jaad.2025.02.001. Epub ahead of print. PMID: 39922285
46. Matthewman J, Mansfield KE, Cadogan SL, Abuabara K, Smith C, Bhaskaran K, Langan SM, Warren-Gash C. Psoriasis and dementia: A population-based matched cohort study of adults in England. Ann Clin Transl Neurol. 2025 Feb;12(2):393-404. doi: 10.1002/acn3.52283. Epub 2025 Jan 1. PMID: 39743756; PMCID: PMC11822786.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Edyta Witkowska, Marcin Ciechański, Klaudia Wilk, Szymon Cholewiński, Bernadetta Wilk, Piotr Stachura, Piotr Rejman, Katarzyna Pszczoła, Katarzyna Jurkiewicz, Aleksandra Kasprzyk

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 313
Number of citations: 0